Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487849 | Journal of Pharmaceutical Sciences | 2007 | 14 Pages |
Abstract
Combination results differed from findings with SIR alone, supporting the observed clinical phenotype with calcineurin inhibitors. These findings may provide a rationale for the development of novel drug delivery strategies to mitigate adverse pharmacodynamic responses.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
A.Scott Mathis, Song Jin, Gary S. Friedman, Felice Peng, Stephen M. Carl, Gregory T. Knipp,